Shi FD - Search Results

1

Natural killer cells in human autoimmunity.

Flodström-Tullberg M, Bryceson YT, Shi FD, Höglund P, Ljunggren HG. Flodström-Tullberg M, et al. Among authors: shi fd. Curr Opin Immunol. 2009 Dec;21(6):634-40. doi: 10.1016/j.coi.2009.09.012. Epub 2009 Nov 4. Curr Opin Immunol. 2009. PMID: 19892538 Review.

2

Natural killer cells determine the outcome of B cell-mediated autoimmunity.

Shi FD, Wang HB, Li H, Hong S, Taniguchi M, Link H, Van Kaer L, Ljunggren HG. Shi FD, et al. Nat Immunol. 2000 Sep;1(3):245-51. doi: 10.1038/79792. Nat Immunol. 2000. PMID: 10973283

3

Organ-specific features of natural killer cells.

Shi FD, Ljunggren HG, La Cava A, Van Kaer L. Shi FD, et al. Nat Rev Immunol. 2011 Sep 23;11(10):658-71. doi: 10.1038/nri3065. Nat Rev Immunol. 2011. PMID: 21941294 Free PMC article. Review.

4

IL-18 directs autoreactive T cells and promotes autodestruction in the central nervous system via induction of IFN-gamma by NK cells.

Shi FD, Takeda K, Akira S, Sarvetnick N, Ljunggren HG. Shi FD, et al. J Immunol. 2000 Sep 15;165(6):3099-104. doi: 10.4049/jimmunol.165.6.3099. J Immunol. 2000. PMID: 10975822

5

Tumor necrosis factor receptor-1 is critically involved in the development of experimental autoimmune myasthenia gravis.

Wang HB, Li H, Shi FD, Chambers BJ, Link H, Ljunggren HG. Wang HB, et al. Among authors: shi fd. Int Immunol. 2000 Oct;12(10):1381-8. doi: 10.1093/intimm/12.10.1381. Int Immunol. 2000. PMID: 11007755

6

Innate immunity and autoimmunity: from self-protection to self-destruction.

Shi FD, Ljunggren HG, Sarvetnick N. Shi FD, et al. Trends Immunol. 2001 Feb;22(2):97-101. doi: 10.1016/s1471-4906(00)01821-4. Trends Immunol. 2001. PMID: 11286711 Review.

7

Mechanisms of nasal tolerance induction in experimental autoimmune myasthenia gravis: identification of regulatory cells.

Shi FD, Li H, Wang H, Bai X, van der Meide PH, Link H, Ljunggren HG. Shi FD, et al. J Immunol. 1999 May 15;162(10):5757-63. J Immunol. 1999. PMID: 10229808

8

Anti-CTLA-4 antibody treatment triggers determinant spreading and enhances murine myasthenia gravis.

Wang HB, Shi FD, Li H, Chambers BJ, Link H, Ljunggren HG. Wang HB, et al. Among authors: shi fd. J Immunol. 2001 May 15;166(10):6430-6. doi: 10.4049/jimmunol.166.10.6430. J Immunol. 2001. PMID: 11342669

9

Differential requirements for CD28 and CD40 ligand in the induction of experimental autoimmune myasthenia gravis.

Shi FD, He B, Li H, Matusevicius D, Link H, Ljunggren HG. Shi FD, et al. Eur J Immunol. 1998 Nov;28(11):3587-93. doi: 10.1002/(SICI)1521-4141(199811)28:11<3587::AID-IMMU3587>3.0.CO;2-Y. Eur J Immunol. 1998. PMID: 9842901 Free article.

10

Role for interferon-gamma in rat strains with different susceptibility to experimental autoimmune myasthenia gravis.

Wang HB, Shi FD, Li H, van der Meide PH, Ljunggren HG, Link H. Wang HB, et al. Among authors: shi fd. Clin Immunol. 2000 May;95(2):156-62. doi: 10.1006/clim.2000.4850. Clin Immunol. 2000. PMID: 10779409

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

260 results

Search Page